{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:37:01Z","timestamp":1792654621543,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-18430-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T17:26:34Z","timestamp":1759253194000},"page":"594-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association Between Long-Term Proton Pump Inhibitor Use and Low-Risk Gastric Neuroendocrine Tumors"],"prefix":"10.1245","volume":"33","author":[{"given":"Taymeyah","family":"Al-Toubah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Pelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintallah","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-218X","authenticated-orcid":false,"given":"Jonathan","family":"Strosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"18430_CR1","doi-asserted-by":"crossref","unstructured":"Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol. 1987;5(10):1502-22.","DOI":"10.1200\/JCO.1987.5.10.1502"},{"issue":"8","key":"18430_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4251\/wjgo.v12.i8.791","volume":"12","author":"M Ahmed","year":"2020","unstructured":"Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020;12(8):791\u2013807.","journal-title":"World J Gastrointest Oncol."},{"issue":"2","key":"18430_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s002689900026","volume":"20","author":"G Rindi","year":"1996","unstructured":"Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20(2):168\u201372.","journal-title":"World J Surg."},{"issue":"5","key":"18430_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.bpg.2005.05.002","volume":"19","author":"G DelleFave","year":"2005","unstructured":"DelleFave G, Capurso G, Milione M, et al. Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol. 2005;19(5):659\u201373.","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"18430_CR5","doi-asserted-by":"crossref","unstructured":"Waldum HL, S\u00f8rdal \u00d8 F, Mj\u00f8nes PG. The enterochromaffin-like [ECL] cell-central in gastric physiology and pathology. Int J Mol Sci. 2019;20(10).","DOI":"10.3390\/ijms20102444"},{"issue":"46","key":"18430_CR6","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.3748\/wjg.v19.i46.8687","volume":"19","author":"S Grozinsky-Glasberg","year":"2013","unstructured":"Grozinsky-Glasberg S, Thomas D, Strosberg JR, et al. Metastatic type 1 gastric carcinoid: a real threat or just a myth? World J Gastroenterol. 2013;19(46):8687\u201395.","journal-title":"World J Gastroenterol."},{"key":"18430_CR7","doi-asserted-by":"crossref","unstructured":"Berna MJ, Hoffmann KM, Long SH, et al. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features. Medicine (Baltimore). 2006;85(6):331-64.","DOI":"10.1097\/MD.0b013e31802b518c"},{"key":"18430_CR8","doi-asserted-by":"crossref","unstructured":"Berna MJ, Hoffmann KM, Serrano J, et al. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore). 2006;85(6):295-330.","DOI":"10.1097\/01.md.0000236956.74128.76"},{"issue":"8","key":"18430_CR9","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3390\/cancers15082202","volume":"15","author":"A Laffi","year":"2023","unstructured":"Laffi A, Lania AGA, Ragni A, et al. Gastric neuroendocrine tumors (g-NETs): a systematic review of the management and outcomes of type 3 g-NETs. Cancers. 2023;15(8):2202.","journal-title":"Cancers."},{"issue":"7","key":"18430_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/01.pas.0000163363.86099.9f","volume":"29","author":"SC Abraham","year":"2005","unstructured":"Abraham SC, Carney JA, Ooi A, et al. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol. 2005;29(7):969\u201375.","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"18430_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00595-009-4032-7","volume":"40","author":"K Nakata","year":"2010","unstructured":"Nakata K, Aishima S, Ichimiya H, et al. Unusual multiple gastric carcinoids with hypergastrinemia: report of a case. Surg Today. 2010;40(3):267\u201371.","journal-title":"Surg Today."},{"issue":"3","key":"18430_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02739887","volume":"6","author":"A Ooi","year":"1995","unstructured":"Ooi A, Ota M, Katsuda S, et al. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr Pathol. 1995;6(3):229\u201337.","journal-title":"Endocr Pathol."},{"issue":"11","key":"18430_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3109\/00365521.2015.1054426","volume":"50","author":"F Cavalcoli","year":"2015","unstructured":"Cavalcoli F, Zilli A, Conte D, et al. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence? Scand J Gastroenterol. 2015;50(11):1397\u2013403.","journal-title":"Scand J Gastroenterol."},{"issue":"9243","key":"18430_CR14","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(05)71964-4","volume":"356","author":"R Dawson","year":"2000","unstructured":"Dawson R, Manson JM. Omeprazole in oesophageal reflux disease. Lancet. 2000;356(9243):1770\u20131.","journal-title":"Lancet."},{"issue":"2","key":"18430_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1018881617038","volume":"43","author":"Y Haga","year":"1998","unstructured":"Haga Y, Nakatsura T, Shibata Y, et al. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci. 1998;43(2):253\u20137.","journal-title":"Dig Dis Sci."},{"issue":"11","key":"18430_CR16","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1046\/j.1365-2036.2001.01097.x","volume":"15","author":"BI Hirschowitz","year":"2001","unstructured":"Hirschowitz BI, Simmons J, Mohnen J. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. Aliment Pharmacol Ther. 2001;15(11):1795\u2013806.","journal-title":"Aliment Pharmacol Ther."},{"issue":"17","key":"18430_CR17","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.2169\/internalmedicine.8701-21","volume":"61","author":"K Kawaguchi","year":"2022","unstructured":"Kawaguchi K, Yashima K, Ikebuchi Y, et al. The first case of gastric neuroendocrine tumors induced by a proton pump inhibitor in von Hippel-Lindau Disease. Intern Med. 2022;61(17):2587\u201392.","journal-title":"Intern Med."},{"issue":"20","key":"18430_CR18","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.3390\/ijms20205128","volume":"20","author":"L Lee","year":"2019","unstructured":"Lee L, Ramos-Alvarez I, Ito T, et al. Insights into effects\/risks of chronic hypergastrinemia and lifelong PPI treatment in man based on studies of patients with Zollinger-Ellison Syndrome. Int J Mol Sci. 2019;20(20):5128.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"18430_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s10620-015-4014-0","volume":"61","author":"N Nandy","year":"2016","unstructured":"Nandy N, Hanson JA, Strickland RG, et al. Solitary gastric carcinoid tumor associated with long-term use of omeprazole: a case report and review of the literature. Dig Dis Sci. 2016;61(3):708\u201312.","journal-title":"Dig Dis Sci."},{"issue":"4","key":"18430_CR20","first-page":"209","volume":"115","author":"PHT Prado","year":"2023","unstructured":"Prado PHT, Paula RV, de Faria ATR, et al. A gastric neuroendocrine tumor after prolonged use of proton pump inhibitors. Rev Esp Enferm Dig. 2023;115(4):209\u201310.","journal-title":"Rev Esp Enferm Dig."},{"issue":"6","key":"18430_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/his.14220","volume":"77","author":"VQ Trinh","year":"2020","unstructured":"Trinh VQ, Shi C, Ma C. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis. Histopathology. 2020;77(6):865\u201376.","journal-title":"Histopathology."},{"issue":"3","key":"18430_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5858\/arpa.2020-0315-OA","volume":"146","author":"R Rais","year":"2022","unstructured":"Rais R, Trikalinos NA, Liu J, et al. Enterochromaffin-like cell hyperplasia-associated gastric neuroendocrine tumors may arise in the setting of proton pump inhibitor use. Arch Pathol Lab Med. 2022;146(3):366\u201371.","journal-title":"Arch Pathol Lab Med."},{"issue":"7","key":"18430_CR23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/apt.12012","volume":"36","author":"CS Jianu","year":"2012","unstructured":"Jianu CS, Fossmark R, Viset T, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther. 2012;36(7):644\u20139.","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"18430_CR24","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41598-020-57612-8","volume":"10","author":"YSH Yang","year":"2020","unstructured":"Yang YSH, Chang HW, Lin IH, et al. Long-term proton pump inhibitor administration caused physiological and microbiota changes in rats. Sci Rep. 2020;10(1):866.","journal-title":"Sci Rep."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18430-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:09:19Z","timestamp":1765289359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18430-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["18430"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18430-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}